"It is particularly noteworthy that MSI-1436 stimulates tissue regeneration in both zebrafish and adult mice, two widely divergent species that are separated by approximately 450 million years of evolution."
Also paper explained that the drug had been applied in Phase 1 clinical trials with humans as a treatment for diabetes and obesity.
"Importantly, the doses we have shown to be effective in stimulating tissue regeneration are 5–50-times lower than the maximum well-tolerated human dose."
